glp-1 obesity drug news today october 16 2025 Alarming rise in weight loss overdoses The Unstoppable Rise of GLP-1
Description
Ozempic: Originally for diabetes but widely used off-label for obesity
However, there was no significant correlation of eotaxin seen in patients with T2DM or impaired glucose tolerance in the KORA cohort (95)
ACS Chem
Microvascular and cardiovascular outcomes according to renal function in patients treated with once-weekly exenatide: insights from the EXSCEL Trial
What are the differences between different types of weight loss medications
A new study reveals how a specific gut bacteria protects your metabolism
